The Cost-Effectiveness of Short-Term Psychodynamic Psychotherapy and Solution-Focused Therapy in the Treatment of Depressive and Anxiety Disorders During a Three-Year Follow-Up

Tiivistelmä

Background

Various psychotherapies are used extensively in treating different mental disorders, but still relatively little is known about the long-term health and cost effects of different therapies. The aim of this study is to compare the cost-effectiveness of short-term psychodynamic psychotherapy (SPP) and solution-focused therapy (SFT) in the treatment of depressive and anxiety disorders during a three-year follow-up.

Methods

A total of 198 outpatients suffering from mood or anxiety disorder were randomized to SPP or SFT. Symptoms were assessed using the Beck Depression Inventory, the Hamilton Depression Rating Scale, the Symptom Check List Anxiety Scale, the Hamilton Anxiety Rating Scale, and the Symptom Check List Global Severity Index. Both direct and indirect costs due to mental health problems were measured.

Results

The symptoms of depression and anxiety were reduced statistically significantly according to all 5 psychiatric outcome measures during the first 7 months, after which only minor changes were observed. The differences between the two groups were small and not statistically significant. The direct costs were about equal in both groups but the indirect costs were somewhat higher in the SPP group, although not statistically significantly. The costs of auxiliary treatments were much higher than the cost of SPP or SFT.

Conclusions

With regard to cost-effectiveness, there is little difference between SPP and SFT.

Lue koko artikkeli (scirp.org)

Tekijät

Timo Maljanen, Tommi Härkänen, Esa Virtala, Olavi Lindfors, Päivi Tillman, Paul Knekt

Lisätietoja julkaisusta

• Vertaisarvioitu: kyllä.
• Avoin saatavuus: kyllä.
• Koko viite: Maljanen, T., Härkänen, T., Virtala, E., Lindfors, O., Tillman, P., & Knekt, P. (2014). The Cost-Effectiveness of Short-Term Psychodynamic Psychotherapy and Solution-Focused Therapy in the Treatment of Depressive and Anxiety Disorders During a Three-Year Follow-Up. Open Journal of Psychiatry, 4(3), 238–250. http://dx.doi.org/10.4236/ojpsych.2014.43030